
TriZetto is owned by Cognizant Technology Solutions (Nasdaq: CTSH), the American IT services multinational headquartered in Teaneck, New Jersey. Cognizant acquired the TriZetto Group in 2014 for approximately $2.7 billion. TriZetto provides claims administration, billing, and eligibility software to health insurers and providers, including its TriZetto Provider Solutions clearinghouse business.
Parent Company
Acquired
2014
Status
Publicly Traded
Headquarters
| Brand | Parent Company | Ownership Type |
|---|---|---|
| TriZetto | Cognizant Technology Solutions Corporation | Subsidiary |
The TriZetto Group was founded in 1997 in Englewood, Colorado, building software for health plan administration. It went public, was taken private in 2008 by Thoma Bravo in a roughly $1.4 billion buyout, and merged with Gateway EDI in 2011 to add provider-side claims services.
Cognizant acquired TriZetto in 2014 for $2.7 billion. The combined offering put Cognizant inside both payer systems (claims administration platforms such as Facets and QNXT) and provider systems (TriZetto Provider Solutions, the former Gateway EDI clearinghouse). The unit processes billions of transactions a year and serves payers and providers covering about 200 million people.
What does Cognizant own?
Cognizant operates a single masterbrand for its services, supported by platform names including Cognizant TriZetto for healthcare payer technology, Neuro and Flowsource for AI delivery, and Skygrade for cloud. It has integrated dozens of acquisitions under the Cognizant name rather than maintaining separate product brands.
Is Cognizant publicly traded?
Yes. Cognizant trades on the Nasdaq under ticker CTSH and is a component of the S&P 500 and Nasdaq-100. It completed its independence from Dun and Bradstreet through a Nasdaq listing in 1998.
Who founded Cognizant?
Cognizant began in 1994 as a software development unit inside Dun and Bradstreet in Chennai, India, and was spun out as an independent company under early leaders including Kumar Mahadeva and Francisco D'Souza. It has no single individual founder in the conventional sense.
Where is Cognizant headquartered?
Cognizant is headquartered in Teaneck, New Jersey, USA. Its delivery workforce is concentrated in India, with major centers in Chennai, Hyderabad, Bengaluru, and Pune, plus additional operations in the Philippines, Eastern Europe, and Latin America.
How many brands does Cognizant own?
Cognizant operates primarily under one masterbrand. Its named offerings, including Cognizant TriZetto, Neuro, Flowsource, and Skygrade, are platforms and practices inside the corporate brand rather than standalone brands with independent identities.
Who owns Cognizant?
Cognizant is publicly owned, with shares distributed among institutional investors and index funds led by Vanguard, BlackRock, and State Street. No founder, family, or single investor controls the company.
What were Cognizant's 2025 results?
For 2025 Cognizant reported revenue of $21.1 billion, up 7.0 percent, GAAP operating margin of 16.1 percent, GAAP EPS of $4.56, adjusted EPS of $5.28, and trailing twelve-month bookings of $28.4 billion. It signed 28 large deals during the year and guided to 4.0 to 6.5 percent constant currency growth for 2026.
TriZetto Provider Solutions disclosed a significant data breach reported in early 2026: an unauthorized actor accessed insurance eligibility transaction reports through a web portal beginning in November 2024, with the incident discovered on October 2, 2025. Filings with state attorneys general put the affected count at approximately 3.4 million individuals, potentially including names, addresses, dates of birth, Social Security numbers, and health insurance details. No payment card or bank data was involved. TPS engaged external cybersecurity experts, notified law enforcement, and offered credit monitoring to affected individuals.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Waystar | USA | 2017 | Mass market | United states | Business | |
| Availity | USA | 2001 | Mass market | United states | Business | |
| Experian | USA | 2013 | Mass market | United states | Business | |
| Unitedhealth Group | USA | 2013 | Mass market | United states | All Genders | |
| Md Clarity | USA | 2010 | Mass market | United states | Business |
Healthcare PharmaceuticalsOwned by Waystar Holding Corp.
Cloud healthcare payments platform used by more than 30,000 providers, operated by Nasdaq-listed Waystar Holding Corp.
Healthcare PharmaceuticalsOwned by Availity
The largest real-time health information network in the US, owned by a consortium of major health insurers and Novo Holdings.
Healthcare PharmaceuticalsOwned by Experian plc
The healthcare revenue cycle and data division of Experian plc, serving providers with eligibility, claims, and patient payment products.
Healthcare PharmaceuticalsOwned by UnitedHealth Group
Healthcare technology company providing claims processing and payment solutions, owned by UnitedHealth Group.
Healthcare PharmaceuticalsOwned by MD Clarity
Seattle healthcare SaaS platform for patient cost estimates, payer contract management, and underpayment detection.
Market Positioning: TriZetto competes with 5 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Looking for brands with different ownership structures? These similar brands are not owned by Cognizant Technology Solutions Corporation, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by Availity
The largest real-time health information network in the US, owned by a consortium of major health insurers and Novo Holdings.
Availity is privately owned, unlike TriZetto which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by MD Clarity
Seattle healthcare SaaS platform for patient cost estimates, payer contract management, and underpayment detection.
MD Clarity is privately owned, unlike TriZetto which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Waystar Holding Corp.
Cloud healthcare payments platform used by more than 30,000 providers, operated by Nasdaq-listed Waystar Holding Corp.
Waystar operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Kenvue
American adhesive bandage brand invented in 1921, owned by Kenvue Inc. Band-Aid is the leading adhesive bandage brand in the United States and is sold in more than 100 countries.
Band-Aid is privately owned, unlike TriZetto which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Kenvue
American brand of antihistamine medication used to treat allergies, itching, and cold symptoms, manufactured and marketed by Johnson & Johnson.
Benadryl is privately owned, unlike TriZetto which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Boots is the UK's leading pharmacy-led health and beauty retailer, founded in 1849, now operating as The Boots Group under Sycamore Partners since August 2025.
Boots is privately owned, unlike TriZetto which is under a publicly traded parent company.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Pfizer's respiratory syncytial virus (RSV) vaccine approved for older adults, maternal immunization to protect infants, and younger at-risk adults. Launched 2023.

Specialty pharmacy founded in 1996 in Memphis, serving patients with complex and rare conditions as the specialty pharmacy of Evernorth within The Cigna Group.